This finding fits well with the strong immunoreactivity of AT8-hyperphosphorylated tau described in the brain parenchyma [57, 83–86] and in cross retinal sections from aged (10-month-old) Tg2576 [6] and human AD cases [15]. Here, MAPT is linked to Alzheimer disease.